Operating Income

Name: Cogent Biosciences, Inc. Operating Income by Business Segments
Creator: OpenCapital
License: https://www.opencapital.sh/terms

Cogent Biosciences, Inc.·Business Segments·7 segments·Rolls up to Operating Income

Breakdown

Segment	Q1 '25	Q2 '25	Q3 '25	Q4 '25	Q1 '26
Latestage Development	$28.1M	$27.12M	$32.23M	$32.62M	$28.1M
Other Operational Infrastructure And Advisory Support	$7.12M	$8.58M	$9.11M	$15.63M	$20.22M
Research And Development Personnel Related	$14.87M	$14.57M	$15.21M	$19.23M	$18.05M
Stock-Based Compensation Expense	$10.01M	$9.72M	$10.6M	$15.75M	$16.91M
Early Stage Preclinical And Discovery Programs	$9.78M	$10.04M	$10.56M	$9.74M	$13.98M
Research And Development Software Facilities And Other Strategic Support	$4.43M	$4.91M	$5.01M	$5.89M	$5.73M
Depreciation Expense	$640K	$655K	$641K	$628K	$626K
Total	-$74.93M	-$75.58M	-$83.36M	-$99.49M	-$103.61M

Depreciation ExpenseView metric

Early Stage Preclinical And Discovery ProgramsView metric

Latestage DevelopmentView metric

Other Operational Infrastructure And Advisory SupportView metric

Research And Development Personnel RelatedView metric

Research And Development Software Facilities And Other Strategic SupportView metric

Stock-Based Compensation ExpenseView metric